{ "cik": 1650664, "cik_padded": "0001650664", "entityName": "Editas Medicine, Inc.", "fiscal_years": [ { "accn": "0001650664-26-000017", "filed": "2026-03-09", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 607000.0, "cash": 146645000.0, "eps_diluted": -1.8, "free_cash_flow": -165848000.0, "net_income": -160060000.0, "operating_cash_flow": -165241000.0, "operating_income": -160010000.0, "revenue": 40520000.0, "stockholders_equity": 27288000.0, "total_assets": 186534000.0, "total_liabilities": 159246000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 5.83575197889182, "revenue_growth_yoy": 0.2539456582286316, "roa_avg2y": -0.60614667416492, "roa_period_end": -0.8580741312575724, "roe_avg2y": -1.9814065188596328 } }, { "accn": "0001650664-26-000017", "filed": "2026-03-09", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 8826000.0, "cash": 131541000.0, "eps_diluted": -2.88, "free_cash_flow": -219110000.0, "net_income": -237093000.0, "operating_cash_flow": -210284000.0, "operating_income": -251152000.0, "revenue": 32314000.0, "stockholders_equity": 134274000.0, "total_assets": 341589000.0, "total_liabilities": 207315000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.5439697931096117, "revenue_growth_yoy": -0.5863702110774036, "roa_avg2y": -0.5640089349645908, "roa_period_end": -0.6940885098759035, "roe_avg2y": -0.9809980325671172, "roe_period_end": -1.765740202868761 } }, { "accn": "0001650664-26-000017", "filed": "2026-03-09", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4719000.0, "cash": 123652000.0, "eps_diluted": -2.02, "free_cash_flow": -136897000.0, "net_income": -153219000.0, "operating_cash_flow": -132178000.0, "operating_income": -169181000.0, "revenue": 78123000.0, "stockholders_equity": 349097000.0, "total_assets": 499153000.0, "total_liabilities": 150056000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.42984041684689356, "revenue_growth_yoy": 2.9632203733766236, "roa_avg2y": -0.30236394816245904, "roa_period_end": -0.3069579868296895, "roe_avg2y": -0.4317384192499898, "roe_period_end": -0.4389009358430465 } }, { "accn": "0001650664-25-000022", "filed": "2025-03-05", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4118000.0, "cash": 141522000.0, "eps_diluted": -3.21, "free_cash_flow": -181467000.0, "net_income": -220432000.0, "operating_cash_flow": -177349000.0, "operating_income": -225950000.0, "revenue": 19712000.0, "stockholders_equity": 360680000.0, "total_assets": 514321000.0, "total_liabilities": 153641000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4259759343462349, "revenue_growth_yoy": -0.22831193235202005, "roa_avg2y": -0.3699131736426459, "roa_period_end": -0.4285883718533756, "roe_avg2y": -0.4821758636454116, "roe_period_end": -0.6111567040035488 } }, { "accn": "0001650664-25-000022", "filed": "2025-03-05", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7977000.0, "cash": 203519000.0, "eps_diluted": -2.85, "free_cash_flow": -171780000.0, "net_income": -192502000.0, "operating_cash_flow": -163803000.0, "operating_income": -193146000.0, "revenue": 25544000.0, "stockholders_equity": 553642000.0, "total_assets": 677483000.0, "total_liabilities": 123841000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.22368425805845654, "revenue_growth_yoy": -0.71846757483578, "roa_avg2y": -0.30798225720650996, "roa_period_end": -0.28414292314345896, "roe_avg2y": -0.4064533565308458, "roe_period_end": -0.34770122208936466 } }, { "accn": "0001650664-24-000008", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7162000.0, "cash": 139682000.0, "eps_diluted": -1.98, "free_cash_flow": -187005000.0, "net_income": -115976000.0, "operating_cash_flow": -179843000.0, "operating_income": -134840000.0, "revenue": 90732000.0, "stockholders_equity": 393586000.0, "total_assets": 572602000.0, "total_liabilities": 179016000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.45483325118271484, "net_margin": -1.2782259842172552, "operating_margin": -1.4861349909623949, "revenue_growth_yoy": 3.419268423359797, "roa_avg2y": -0.21447506997310184, "roa_period_end": -0.2025420798390505, "roe_avg2y": -0.3535729692404077, "roe_period_end": -0.29466495251355485 } }, { "accn": "0001558370-23-001764", "filed": "2023-02-22", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6167000.0, "cash": 238183000.0, "eps_diluted": -2.68, "free_cash_flow": -46836000.0, "net_income": -133746000.0, "operating_cash_flow": -40669000.0, "operating_income": -140922000.0, "revenue": 20531000.0, "stockholders_equity": 262437000.0, "total_assets": 508885000.0, "total_liabilities": 246448000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9390749017859524, "revenue_growth_yoy": -0.35714062059679996, "roa_avg2y": -0.2878514448422473, "roa_period_end": -0.26282165911748234, "roe_avg2y": -0.5364872372387429, "roe_period_end": -0.5096308828404531 } }, { "accn": "0001558370-22-001950", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4754000.0, "cash": 134776000.0, "free_cash_flow": -50461000.0, "net_income": -109954000.0, "operating_cash_flow": -45707000.0, "operating_income": -113727000.0, "revenue": 31937000.0, "stockholders_equity": 236162000.0, "total_assets": 420386000.0, "total_liabilities": 184224000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7800746944893759, "revenue_growth_yoy": 1.32641317016317, "roa_avg2y": -0.27708575359795173, "roa_period_end": -0.26155485672691287, "roe_avg2y": -0.49501848091805817, "roe_period_end": -0.46558718168037194 } }, { "accn": "0001558370-21-001915", "filed": "2021-02-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2059000.0, "cash": 146630000.0, "free_cash_flow": -11476000.0, "net_income": -120324000.0, "operating_cash_flow": -9417000.0, "operating_income": -119933000.0, "revenue": 13728000.0, "stockholders_equity": 208080000.0, "total_assets": 373260000.0, "total_liabilities": 165180000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7938292964244521, "roa_avg2y": -0.39945422131923075, "roa_period_end": -0.32235974923645716, "roe_avg2y": -0.7022384858486024, "roe_period_end": -0.5782583621683968 } }, { "accn": "0001558370-20-001476", "filed": "2020-02-26", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3493000.0, "cash": 185323000.0, "free_cash_flow": -53739000.0, "net_income": -97183000.0, "operating_cash_flow": -50246000.0, "operating_income": -97188000.0, "stockholders_equity": 134607000.0, "total_assets": 229182000.0, "total_liabilities": 94575000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7026009048563596, "roa_period_end": -0.42404290040230036, "roe_period_end": -0.7219758259228718 } } ], "latest_filing": { "accn": "0001650664-26-000017", "filed": "2026-03-09", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001650664.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001650664.json" }, "ticker": "EDIT" }